- Home
- ZKH vs TSHA Comparison
ZKH vs TSHA Comparison
Compare ZKH & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKH
- TSHA
- Stock Information
- Founded
- ZKH 1998
- TSHA 2019
- Country
- ZKH China
- TSHA United States
- Employees
- ZKH N/A
- TSHA N/A
- Industry
- ZKH
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- ZKH
- TSHA Health Care
- Exchange
- ZKH Nasdaq
- TSHA Nasdaq
- Market Cap
- ZKH 472.2M
- TSHA 397.8M
- IPO Year
- ZKH 2023
- TSHA 2020
- Fundamental
- Price
- ZKH $2.78
- TSHA $2.69
- Analyst Decision
- ZKH Buy
- TSHA Strong Buy
- Analyst Count
- ZKH 1
- TSHA 7
- Target Price
- ZKH $4.00
- TSHA $7.00
- AVG Volume (30 Days)
- ZKH 22.6K
- TSHA 5.2M
- Earning Date
- ZKH 05-20-2025
- TSHA 05-15-2025
- Dividend Yield
- ZKH N/A
- TSHA N/A
- EPS Growth
- ZKH N/A
- TSHA N/A
- EPS
- ZKH N/A
- TSHA N/A
- Revenue
- ZKH $1,217,705,644.00
- TSHA $7,224,000.00
- Revenue This Year
- ZKH $11.95
- TSHA N/A
- Revenue Next Year
- ZKH $11.23
- TSHA N/A
- P/E Ratio
- ZKH N/A
- TSHA N/A
- Revenue Growth
- ZKH 2.24
- TSHA N/A
- 52 Week Low
- ZKH $2.50
- TSHA $1.05
- 52 Week High
- ZKH $13.97
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- ZKH 42.77
- TSHA 60.38
- Support Level
- ZKH $2.60
- TSHA $2.44
- Resistance Level
- ZKH $3.16
- TSHA $2.95
- Average True Range (ATR)
- ZKH 0.24
- TSHA 0.24
- MACD
- ZKH -0.00
- TSHA -0.02
- Stochastic Oscillator
- ZKH 42.55
- TSHA 48.54
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.